• Marica Salvetto
  • Marco Daperno


Ileocolonoscopy is at present an essential tool for diagnosis of inflammatory bowel disease (IBD), disease assessment for prognostic purposes and therapeutic interventions. Severe endoscopic lesions are associated with higher risk since most severe endoscopic findings are associated with an increased rate of surgery and poor outcome in both Crohn’s disease and ulcerative colitis. Patients with an improvement of mucosal lesions after treatment have a good prognosis and no or slow disease progression.

Capsule endoscopy is a complimentary technique to visualize small bowel lesions. It has limited but extremely valuable indications in inflammatory bowel disease diagnosis and assessment. Upper GI endoscopy is less commonly used in the standard diagnostic workup of adult inflammatory bowel disease. However, it can be used to supplement other diagnostic techniques in selected cases.

Classification of disease activity according to endoscopic scores is essential for clinical trials as they contribute to a more objective disease assessment and allow for subsequent evaluation and grading of disease variation. The most commonly used scoring systems are Mayo endoscopic subscore and UCEIS (ulcerative colitis endoscopic index of severity) for ulcerative colitis, Rutgeerts’ score for postsurgical Crohn’s disease and CDEIS (Crohn’s disease endoscopic index of severity) and SES-CD (simplified endoscopic score for Crohn’s disease) for the assessment of ileocolonic Crohn’s disease. However, there are some limitations that have to be considered when using endoscopic scores.

Patients affected by IBD may require special nursing care as they are likely to require several endoscopic examinations during their lifetime which may result in higher anxiety. This care extends to endoscopic-specific counselling as well as bowel-cleansing prescription and sedation planning.


  1. Annese V, Daperno M, Rutter MD et al (2013) European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 7(12):982–1018CrossRefGoogle Scholar
  2. Daperno M, D’Haens G, Van Assche G et al (2004) Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 60(4):505–512CrossRefGoogle Scholar
  3. Daperno M, Comberlato M, Bossa F et al (2017) Training programs on endoscopic scoring systems for inflammatory bowel disease lead to a significant increase in interobserver agreement among community gastroenterologists. J Crohns Colitis 11(5):556–561PubMedGoogle Scholar
  4. Gomollón F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis 11(1):3–25CrossRefGoogle Scholar
  5. Magro F, Gionchetti P, Eliakim R et al (2017) Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis 11(6):649–670CrossRefGoogle Scholar
  6. Mary JY, Modigliani R (1989) Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 30(7):983–989CrossRefGoogle Scholar
  7. Pera A, Bellando P, Caldera D et al (1987) Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 92(1):181–185CrossRefGoogle Scholar
  8. Rutgeerts P, Geboes K, Vantrappen G et al (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99(4):956–956CrossRefGoogle Scholar
  9. Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317(26):1625–1629CrossRefGoogle Scholar
  10. Shah SC, Colombel JF, Sands BE et al (2016a) Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn’s disease. Aliment Pharmacol Ther 43(3):317–333CrossRefGoogle Scholar
  11. Shah SC, Colombel JF, Sands BE et al (2016b) Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 14(9):1245–1125CrossRefGoogle Scholar
  12. Travis SP, Schnell D, Krzeski P et al (2013) Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology 145(5):987–995CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Marica Salvetto
    • 1
  • Marco Daperno
    • 1
  1. 1.Gastroenterology UnitMauriziano HospitalTorinoItaly

Personalised recommendations